Home › Funds › Zweig-DiMenna Associates LLC › NTRA

Zweig-DiMenna Associates LLC position in NTRA

NATERA INC · Health Care

Zweig-DiMenna Associates LLC reported holding 84,222 shares of NTRA (NATERA INC) in its Q3 2026 13F filing — a position valued at US$34.8M, representing 2.76% of its reported portfolio and ranking #7 among its reported holdings. Zweig-DiMenna Associates LLC has disclosed NTRA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)84.22K sh
Reported value held$34.81M
Portfolio Weight2.76%
First reportedQ2 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Zweig-DiMenna Associates LLC's NTRA position evolved

Zweig-DiMenna Associates LLC first disclosed a stake in NTRA in Q2 2024 at 77,525 shares (US$8.4M). The position peaked in Q4 2024 at 229,365 shares, worth US$36.3M. Across 10 filings, Zweig-DiMenna Associates LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 84,222 shares valued at US$34.8M — an increase of 2,240 shares quarter over quarter.. Notable position changes include a 213% increase in Q3 2024 (shares rose 24% over the following quarter), a 47% trim in Q1 2025 (shares rose 19% over the following quarter), a 43% trim in Q1 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 77.53K $8.40M New
Q3 2024 242.62K $30.80M Add
Q4 2024 229.37K $36.31M Reduce
Q1 2025 120.49K $17.04M Reduce
Q2 2025 124.10K $20.97M Add
Q3 2025 132.50K $21.33M Add
Q4 2025 134.80K $30.88M Add
Q1 2026 76.25K $15.25M Reduce
Q2 2026 81.98K $22.25M Add
Q3 2026 84.22K $34.81M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NTRA and 13F data

NTRA (NATERA INC) is a Health Care company. 55 other funds we track also report a position in NTRA — the largest reported positions include Fidelity Management & Research (FMR) (US$5.65B), Duquesne Family Office LLC (US$864.9M), Castle Hook Partners LP (US$704.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NTRA

All NTRA fund holders →

FAQ

How long has Zweig-DiMenna Associates LLC held NTRA?

Zweig-DiMenna Associates LLC has disclosed NTRA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Zweig-DiMenna Associates LLC's current position in NTRA?

As of Q3 2026, Zweig-DiMenna Associates LLC holds 84.22K shares of NTRA (NATERA INC), valued at $34.81M, representing 2.76% of its reported portfolio and ranking #7.

Has Zweig-DiMenna Associates LLC been buying or selling NTRA?

In the latest 13F filing (Q3 2026), Zweig-DiMenna Associates LLC increased its position in NTRA. The position peaked in Q4 2024 at 229.37K shares.

Which other funds hold NTRA?

Other major institutional holders of NTRA include Fidelity Management & Research (FMR), Duquesne Family Office LLC, Castle Hook Partners LP, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.